A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%
Status:
Completed
Trial end date:
2015-10-19
Target enrollment:
Participant gender:
Summary
The objective of this study is to identify any adverse events or adverse drug reactions
through post-marketing surveillance under routine clinical practice